Fig. 2From: Successful thrombolytic therapy with recombinant tissue plasminogen activator in ischemic stroke after idarucizumab administration for reversal of dabigatran: a case reportFollow-up magnetic resonance (MR) images on day 4. Diffusion-weighted MR image showing prominent regression of the hyperintense lesion (a, b). T2-weighted MR image showing small high-intensity spots in bilateral putamen due to old ischemic lesion, but no new abnormality was observed in the posterior limb of the left internal capsule (c, d)Back to article page